Bionebraska, Inc.
Records under this name other than patents Bionebraska, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,706,689 | Treatment of acute coronary syndrome with GLP-1 Formerly held Term ended Term ended Jun 10, 2021 · USPTO record | Term ended | Term ended Jun 10, 2021 | USPTO record |
| US 6,316,224 | Chlorella virus promoters Formerly held Term ended Term ended Sep 21, 2019 · USPTO record | Term ended | Term ended Sep 21, 2019 | USPTO record |
| US 7,981,861 | Method of performing angioplasty with a GLP-1 molecule Formerly held Lapsed on the fee record Ended Jul 19, 2019 · USPTO record | Lapsed on the fee record | Ended Jul 19, 2019 | USPTO record |
| US 7,265,087 | Exendin improves β-cell response in subjects with impaired glucose tolerance Formerly held Term ended Term ended May 7, 2019 · USPTO record | Term ended | Term ended May 7, 2019 | USPTO record |
| US 6,284,725 | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue Formerly held Term ended Term ended Apr 30, 2019 · USPTO record | Term ended | Term ended Apr 30, 2019 | USPTO record |
| US 6,998,387 | Human appetite control by glucagon-like peptide receptor binding compounds Formerly held Term ended Term ended Mar 16, 2019 · USPTO record | Term ended | Term ended Mar 16, 2019 | USPTO record |
| US 6,894,024 | Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide Formerly held Lapsed on the fee record Ended May 17, 2017 · USPTO record | Lapsed on the fee record | Ended May 17, 2017 | USPTO record |
| US 6,395,965 | Plant Containing a Gene Construct Comprising a Chlorella Virus Promoter and a Lac Operator Formerly held Term ended Term ended Mar 21, 2017 · Medium confidence | Term ended | Term ended Mar 21, 2017 | Medium confidence |
| US 6,461,834 | Clostripain catalyzed amidation of peptides Formerly held Lapsed on the fee record Ended Oct 8, 2014 · USPTO record | Lapsed on the fee record | Ended Oct 8, 2014 | USPTO record |
| US 6,403,361 | Enzymatic method for modification of recombinant polypeptides Formerly held Term ended Term ended Jul 20, 2013 · USPTO record | Term ended | Term ended Jul 20, 2013 | USPTO record |